Medical House makes strides with needle-free device
This article was originally published in Clinica
Surfing on rolling wave, UK needle-free device company The Medical House this week added Canada to the lengthening list of countries where it has set up new distribution agreements for its mhi-500 insulin delivery technology. The Sheffield- based company's seven-year exclusive deal with Tri-Q Health should bring in aggregate revenues in excess of £3.5m ($5.5m), it estimates. Regulatory approval is expected by Q2 2004.